CLASS II Drug recall · Reported 13 May 2015 · FDA Enforcement Report

Alinia (nitazoxanide), powder for oral suspension, 100mg recalled

Romark Laboratories L.C is recalling Alinia (nitazoxanide), powder for oral suspension, 100mg, distributed nationwide in the US. The recall was initiated on 24 Apr 2015 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot #: MTEW1721, MTCW21281, MTCW21291, Exp 09/2016; Lot #: MTEW5791, Exp 12/2016; Lot #: MTEW5801, Exp 01/2017.
Quantity recalled32,893 bottles

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0983-2015
FDA event ID
70914
Recalling firm
Romark Laboratories L.C, Tampa, FL
Classification
Class II
Status
Terminated
Recall initiated
24 Apr 2015
FDA classified
4 May 2015
Reported
13 May 2015
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Potency & Assay

Timeline

24 Apr 2015Recall initiated by company
4 May 2015Classified by FDA+10 days
13 May 2015Published in enforcement report+9 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Failed Stability Specifications: Product failed to meet 12 months long term stability specification for viscosity

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

Alinia (nitazoxanide), powder for oral suspension, 100mg/5mL, 60 mL/bottle. Rx only, Manufactured for Lupin Pharmaceuticals Inc, Baltimore, Maryland 21202 for Romark Laboratories 3000 Bayport Dr. Suite 200, Tampa, FL 33607

Where it was distributed

Nationwide

Nationwide

Questions about this recall

Why was it recalled?

Failed Stability Specifications: Product failed to meet 12 months long term stability specification for viscosity

Which lots are affected?

Lot #: MTEW1721, MTCW21281, MTCW21291, Exp 09/2016; Lot #: MTEW5791, Exp 12/2016; Lot #: MTEW5801, Exp 01/2017.

Where was it sold?

Nationwide

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.